ARCHIVES

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

This article is from The Cancer Letter archive.

Vol. 16 No. 29 | July 20, 1990

Download PDF Visit The Full Archive

Related Articles

In Brief: Fishman La Jolla President Emeritus, Ruoslahti Succeeds Him; Ariz. Seeks Meyskins Replacement

January 13, 1989

ORI Finds St. Mary’s Data Managers Falsified Data In BCPT

September 8, 1995

House Members Who Voted for Veto

January 3, 1986

Cause Of Allergic Reaction To Cetuximab Found

March 28, 2008

GAO Report Refutes Charges Against Control Program

May 30, 1980

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005